Immunomodulatory and clinical effects of long-term low-dose macrolide treatment of chronic rhinosinusitis with nasal polyposis

Journal of Medical Biochemistry

Volumn 30, Issue 1, 2011, Pages 45-50

  Perić, Aleksandar ^a   Vojvodić, Danilo ^a   Baletić, Nenad ^a   Perić, Aneta ^a   Miljanović, Olivera ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF MONTENEGRO   (Montenegro)

Author keywords

chronic rhinosinusitis; clarithromycin; cytokines; IL 8; nasal fluid; nasal polyposis; TNF

Indexed keywords

CLARITHROMYCIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MACROLIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHRONIC SINUSITIS; CLINICAL ARTICLE; DRUG EFFICACY; ENDOSCOPY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; LOW DRUG DOSE; MALE; NOSE MUCUS; NOSE POLYP; TREATMENT DURATION;

EID: 78649638733     PISSN: 14528258     EISSN: 14528266     Source Type: Journal    
DOI: 10.2478/v10011-010-0043-6     Document Type: Article

References (25)

1. Assanasen P, Naclerio RM. Medical and surgical management of nasal polyps. Curr Opin Otolaryngol Head Neck Surg 2001; 9: 27-36.
2. Nonaka M, Pawankar R, Saji F, et al. Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts. Int Arch Allergy Immunol 1999; 119: 314-21.
3. Demirel T, Orhan KS, Kele N, Deer K. Comparison of the efficacy of nasal drop and nasal spray application of fluticasone propionate in nasal polyps. Kulak Burun Bogaz Ihtis Derg 2008; 18: 1-6.
4. Cervin A, Kalm O, Sandkull P, Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002; 126: 481-9.
5. Riechelmann H, Deutschle T, Friemel E, Gross HJ, Bachem M. Biological markers in nasal secretions. Eur Respir J 2003; 21: 600-5.
6. Tsicopoulos A, Shimbara A, de Nadai P, Aldewachi O, Lamblin C, Lassalle P, et al. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol 2004; 113: 462-9.
7. Malm L. Assessment and staging of nasal polyposis. Acta Otolaryngol 1997; 117: 465-7.
8. Bachert C, Van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999; 118: 375-9.
9. Peri A, Vojvodi D, Radulovi V. Cytokine profiles in nasal fluid in patients with nasal polyps: a flow cytometric study. Journal of Medical Biochemistry 2010; 29: 28-33.
10. Peri A, Vojvodi D, Radulovi V, Miljanovi O. Cytokine levels in nasal secretions in asthmatic and nonasthmatic patients with nasal polyposis. Kulak Burun Bogaz Ihtis Derg 2010; 20: 111-17.
11. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996; 23: 48-56.
12. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000; 143-8.
13. Aydin E, Ortapamuk H, Korkmaz H, Dursun E, Saylam G, Dali M. Clinical and rhinoscintigraphic evaluation of oral macrolides in the management of sinonasal polyposis. Turk J Med Sci 2008; 38: 465-70.
14. Tamaoki J, Takeyama K, Yamawaki I, Kondo M, Konno K. Lipopolysaccharide- induced goblet cell hypersecretion in the guinea pig trachea: inhibition by macrolides. Am J Physiol 1997; 272: 15-19.
15. Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 1996; 525: 73-8.
16. Nonaka M, Pawankar R, Tomiyama S, Yagi T. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 1999; 13: 267-72.
17. Cervin A, Wallwork B. Macrolide therapy of chronic rhinosinusitis. Rhinology 2007; 45: 259-67.
18. Nonaka M, Pawankar R, Saji F, Yagi T. Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol Suppl 1998; 539: 71-5.
19. Pohl D, Andrýs C, Borská L, Fiala Z, Hamáková K, Ettler K, et al. CC and CXC chemokines patterns in psoriasis determined by protein array method were influenced by Goeckerman's therapy. Acta Medica (Hradec Králové) 2009; 52: 9-13.
20. Jurǐić V, Čolić S, Jurǐić M. The inflammatory radicular cysts have higher concentration of TNF-a in comparison to odontogenic keratocysts (odontogenic tumour). Acta Medica (Hradec Králové) 2007; 50: 233-8.
21. Van Pelt J, Romijn F. Long-term Quality Control of the cytokine growth factors and cell adhesion molecule arrays at the Randox Evidence Investigator. Journal of Medical Biochemistry 2009; 28: 300-4.
22. Dordević V, Zvezdanović L, Čosić V, Vlahović P, Kundalić S, Jevtović-Stoimenov T, et al. Serum levels and in vitro production of Th1-and Th2-type cytokines by peripheral blood mononuclear cells in patients suffering from systemic lupus erythematosus. Journal of Medical Biochemistry 2010; 29: 19-27.
23. Ohori J, Ushikai M, Sun D, Nishimoto K, Sagara Y, Fukuiwa T, et al. TNF-a upregulates VCAM-1 and NF-kB in fibroblasts from nasal polyps. Auris Nasus Larynx 2007; 34: 177-83.
24. Saji F, Nonaka M, Pawankar R. Expression of RANTES by IL-1b and TNF-a stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000; 27: 247-52.
25. Yoshifuku K, Matsune S, Ohori J, Sagara Y, Fukuiwa T, Kurono Y. IL-4 and TNF-a increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 2007; 45: 235-41.